Mindray Medical International Ltd (ADR)  

(Public, NYSE:MR)   Watch this stock  
Find more results for NYSE: MR
0.00 (0.00%)
Mar 3 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 27.85 - 27.95
Open     -
Vol. 0.00
Mkt cap 3.31B
P/E 18.80
Div/yield 0.40/1.43
EPS 1.49
Shares 88.18M
Beta     -
Inst. own 86%

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 15.93% 15.04%
Operating margin 17.92% 14.55%
EBITD margin - 19.30%
Return on average assets 8.37% 8.00%
Return on average equity 12.70% 12.40%
Employees 8,400 -
CDP Score - D


Mindray Building Keji 12th Road South, Hi-tech Ind. Park Nanshan
+86-755-26582888 (Phone)
+86-755-26582680 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.